$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong's Insilico Medicine, FT says
07:15am, Sunday, 29'th Mar 2026
Eli Lilly will sign a $2 billion deal with Hong Kong-listed biotech Insilico Medicine , which uses artificial intelligence for drug discovery, the Financial Times reported on Sund
Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study Late-breaking results also pu
1 Reason Eli Lilly Stock Is Still a Buy
06:00am, Saturday, 28'th Mar 2026
Eli Lilly boasts competitive margins by industry standards. Several initiatives could help the company improve on that front.
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
11:00am, Friday, 27'th Mar 2026
One of these companies' lineup and pipeline within weight management and outside look much stronger. Valuation does not tip the scale in the other's favor.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:02am, Friday, 27'th Mar 2026
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to four years 75% of patients achieved a high bar of near-complete skin clearanc
Sen. Angus S. King Jr. Sells Off Shares of Blackstone Inc. (NYSE:BX)
02:42am, Thursday, 26'th Mar 2026
Senator Angus S. King Jr. (Independent-Maine) recently sold shares of Blackstone Inc. (NYSE: BX). In a filing disclosed on March 24th, the Senator disclosed that they had sold between $1,001 and $15,0
Meta Platforms (NASDAQ:META) Shares Unloaded Sen. Angus S. King Jr.
02:42am, Thursday, 26'th Mar 2026
Senator Angus S. King Jr. (Independent-Maine) recently sold shares of Meta Platforms, Inc. (NASDAQ: META). In a filing disclosed on March 24th, the Senator disclosed that they had sold between $1,001
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
06:46pm, Wednesday, 25'th Mar 2026
The latest trading day saw Eli Lilly (LLY) settling at $916.31, representing a +1.47% change from its previous close.
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
09:56am, Wednesday, 25'th Mar 2026
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.
Armstrong Advisory Group Inc. Sells 577 Shares of Eli Lilly and Company $LLY
02:15pm, Tuesday, 24'th Mar 2026
Armstrong Advisory Group Inc. lowered its position in Eli Lilly and Company (NYSE: LLY) by 6.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 8,193 shares
Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF
12:30pm, Tuesday, 24'th Mar 2026
The healthcare sector is selling off in lockstep with the broader market. Eli Lilly's growth is heavily dependent on weight loss drugs.
What's Going On With Eli Lilly On Monday?
01:20pm, Monday, 23'rd Mar 2026
More than 80 global executives gathered in Beijing for the China Development Forum, signaling renewed corporate interest in the Chinese market despite ongoing geopolitical tensions.
Household names were among the more than 30 U.S. corporate executives who joined the China Development Forum in Beijing over the weekend. Fresh off a recovery in Apple iPhone sales in China, CEO Tim C
MassMutual Private Wealth & Trust FSB Acquires 665 Shares of Eli Lilly and Company $LLY
06:52am, Monday, 23'rd Mar 2026
MassMutual Private Wealth and Trust FSB grew its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 2.6% during the undefined quarter, according to its most recent filing with the Securities a
Sign In
Buy LLY